second interim analysis of the emn02 trial
Published 5 years ago • 96 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
2:40
the role of consolidation therapy in mm and updates from the emn02 trial
-
1:05
consolidation therapy and updated results from the emn02 trial
-
3:40
master class in transplantation and hematology: highlights
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
3:17
pet imaging to predict treatment outcomes: follow-up from the echelon-2 trial
-
21:38
drawing the line: the rationale behind blood tube collection order
-
32:52
hematology 2-1_introduction to hemostasis
-
4:12
what is interim analysis in clinical trials ?
-
2:51
analysis of the imerge trial: the disease-modifying potential of imetelstat in lr-mds
-
2:28
results from the cartitude-2 trial
-
0:50
insights into the phase ii window-2 trial
-
2:03
an update on the phase ii/iii imerge trial of imetelstat in lr-mds
-
1:47
shared treatment decision-making
-
4:11
highlights from ims 2024: key clinical trials presented
-
1:07
the second revision of the international staging system for os in mm
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:25
the recent approval of imetelstat in lr-mds based on results of the imerge trial
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv